Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,297,870 papers from all fields of science
Search
Sign In
Create Free Account
C14orf2 gene
Known as:
CHROMOSOME 14 OPEN READING FRAME 2
, MP68
, C14orf2
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
C14orf1 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
MP68-17 MANAGEMENT OF PATIENTS DIAGNOSED WITH ANGIOMYOLIPOMA ACCORDING TO EAU GUIDELINES: PROFILE OF SURGICAL ADVERSE EVENTS TO AID CLINICAL DECISION MAKING
A. Nini
,
A. Larcher
,
+13 authors
R. Bertini
2020
Corpus ID: 218959735
managed with preoperative anticoagulation. The cohort consisted of 32 (58.2%) grade I, 13 (23.6%) grade II, 6 (10.9%) grade III…
Expand
2020
2020
MP68-08 UNEXPECTED PATHOLOGIC UPSTAGING OF CLINICALLY LOCALISED KIDNEY CANCER
A. D. Hauteclocque
,
C. Dariane
,
+17 authors
J. Bernhard
2020
Corpus ID: 218935533
2020
2020
MP68-20 THE PREDICTIVE VALUE OF BODY MASS INDEX AND MAYO ADHESIVE PROBABILITY SCORE IN SURGICAL OUTCOMES AND THEIR ROLE IN SURGICAL CONVERSION IN PATIENTS WITH CLINICAL STAGE I RENAL CELL CARCINOMA
G. Méndez
,
B. González-Sánchez
,
+6 authors
F. Gabilondo-Navarro
2020
Corpus ID: 218949249
INTRODUCTION AND OBJECTIVE: Nephron-sparing surgery (NSS) is the standard of care in tumors less than 4cm, although trends are…
Expand
2019
2019
MP68-20 ESTABLISHING A NEGATIVE FEEDBACK LOOP BETWEEN FIBROBLAST GROWTH FACTOR 5 AND ANDROGEN RECEPTOR IN PROSTATE CANCER
Dalton T. McLean
,
K. Cunningham
,
W. Ricke
Journal of Urology
2019
Corpus ID: 150209441
INTRODUCTION AND OBJECTIVES: Prostate cancer (PRCA) is the 3rd most prevalent type of cancer behind breast and lung cancer, with…
Expand
2019
2019
MP68-10 HOXB13 EXPRESSION AND ITS ROLE IN PROSTATE CANCER PROGRESSION AND NEUROENDOCRINE DIFFERENTIATION
Farzana A. Faisal
,
M. Alshalalfa
,
+4 authors
E. Schaeffer
Journal of Urology
2019
Corpus ID: 96435053
INTRODUCTION AND OBJECTIVES: HOXB13 expression is involved in normal prostate development, is a known regulator of androgen…
Expand
2019
2019
MP68-18 ENZALUTAMIDE TREATMENT RESULTS IN ANTI-ANDROGEN RESISTANCE IN PATIENT-DERIVED BONE METASTATIC PROSTATE CANCER MODELS
C. Jamieson
,
Michelle Muldong
,
+10 authors
C. Kane
Journal of Urology
2019
Corpus ID: 149790237
INTRODUCTION AND OBJECTIVES: Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer associated with…
Expand
Review
2019
Review
2019
MP68-01 IMMUNE COMPOSITION CONTRIBUTES TO PROSTATE MRI APPEARANCE
Eric Kim
,
D. Cao
,
J. Ippolito
,
R. Pachynski
,
G. Andriole
Journal of Urology
2019
Corpus ID: 149895691
INTRODUCTION AND OBJECTIVES: Recently, the clinical use of prostate multiparametric magnetic resonance imaging (mpMRI) has been…
Expand
2015
2015
Abstract MP68: Risk of Sleep Apnea and Subclinical Cardiovascular Disease in Young-to-Middle Aged Adults: The Bogalusa Heart Study
Tian Hu
,
S. Bertisch
,
Wei Chen
,
E. Harville
,
S. Redline
,
L. Bazzano
2015
Corpus ID: 70538236
Obstructive sleep apnea (OSA) may affect cardiovascular risk. Prior studies examining this issue have often been limited to…
Expand
2014
2014
Abstract MP68: Age at Menarche is Inversely Associated with Liver Steatosis and Abdominal Fat Depots: CARDIA Study
N. Mueller
,
Mark A Pereira
,
+5 authors
D. Jacobs
2014
Corpus ID: 70887691
Introduction: Age at menarche is associated with cardiometabolic disease risk later in life; whether hepatic steatosis (fatty…
Expand
2014
2014
Abstract W MP68: MRI Infarct Patterns Do Not Predict Long-Term Cardiac Rhythm Recorder Findings
K. Phoa
,
M. Kate
,
A. Shuaib
,
Ibrahim Ahmad Bany Yaseen
,
K. Butcher
,
B. Buck
Stroke
2014
Corpus ID: 70983623
Intro: It has been hypothesized that stroke/TIA patients with occult paroxysmal atrial fibrillation (PAF) have characteristic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE